Title
Uticaj medikamentne terapije benigne hiperplazije prostate na seksualni život, funkciju i simptome donjeg urinarnog trakta : doktorska disertacija
Creator
Stojanović, Nebojša A. 1959-
Copyright date
2014
Object Links
Select license
Autorstvo-Nekomercijalno-Deliti pod istim uslovima 3.0 Srbija (CC BY-NC-SA 3.0)
License description
Dozvoljavate umnožavanje, distribuciju i javno saopštavanje dela, i prerade, ako se navede ime autora na način odredjen od strane autora ili davaoca licence i ako se prerada distribuira pod istom ili sličnom licencom. Ova licenca ne dozvoljava komercijalnu upotrebu dela i prerada. Osnovni opis Licence: http://creativecommons.org/licenses/by-nc-sa/3.0/rs/deed.sr_LATN Sadržaj ugovora u celini: http://creativecommons.org/licenses/by-nc-sa/3.0/rs/legalcode.sr-Latn
Language
Serbian
Cobiss-ID
Theses Type
Doktorska disertacija
Other responsibilities
mentor
Ignjatović, Ivan
član komisije
Đorđević, Nebojša
član komisije
Stojanović, Miroslav
član komisije
Bašić, Dragoslav
član komisije
Aleksić, Predrag
Academic Expertise
Medicinske nauke
University
Univerzitet u Nišu
Faculty
Medicinski fakultet
Group
Katedra za hirurgiju
Title translated
THE IMPACT OF MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ON SEXUAL LIFE, FUNCTION AND LOWER URINARY TRACT SYMPTOMS
Publisher
Niš : [N. A. Stojanović]
Format
PDF/A (122 lista)
description
Umnoženo za odbranu.
Univerzitet u Nišu, Medicinski fakultet, 2014.
Bibliografija: listovi 92-107.
Sažetak ; Summary.
Abstract (en)
Introduction. Benign prostatic hyperplasia (BPH) causes disorders of voiding and sexual
function. Pharmacologic therapy reduces symptoms of voiding thus impacting sexual
function.
Objective. Determining sex life status in men with BPH before and after pharmacologic
treatment adapted to achieve satisfactory sexual function, and the impact this treatment on
the function and lower urinary tract symptoms.
Methods. 156 sexually active patients not previously treated for BPH were studied. After
clinical examinations, symptoms of voiding, sexual and ejaculatory function were measured
using standardized IPSS, IIEF and MSHQ-EjD questionnaires. After obtaining patients’
opinion about the importance of their sex life, the therapy was chosen and possible side
effects explained. Four groups each of 39 respondents were formed. One group used alphablockers,
tamsulosin, the second 5-alpha reductase inhibitor, finasteride, the third was
administered combination therapy and the fourth control group without therapy. The
complete examination procedure was repeated after 3 and 6 months of therapy.
Results. The mean age of patients was 61.16 2.97. In the therapy groups 87% reported their
sex life was important to some degree. Satisfaction with their sex life was reported by 47% of
patients before treatment and 67% 6 months after treatment. Questionnaire indicated general
improvement of sexual function (IIEF) in all groups statistically significant compared to
baseline only in the group on alpha-blockers (2.95 7.81; p=0.028). Overall satisfaction with
sex life compared to the beginning of treatment is significantly improved only in the group
with combined therapy.
Conclusion. Before treatment BHP, should be evaluated sexual function. Customize therapy
to patient’s expectations. Present side effects of drugs, especially to those emphasizing the
importance of sex life in order to improve it.
Authors Key words
Prostata, seksualni život; tamsulosin; finasterid
Authors Key words
prostate; sexual life; tamsulosin; finasterid
Subject
616
Type
monograph
manuscript text - theses
Text
Abstract (en)
Introduction. Benign prostatic hyperplasia (BPH) causes disorders of voiding and sexual
function. Pharmacologic therapy reduces symptoms of voiding thus impacting sexual
function.
Objective. Determining sex life status in men with BPH before and after pharmacologic
treatment adapted to achieve satisfactory sexual function, and the impact this treatment on
the function and lower urinary tract symptoms.
Methods. 156 sexually active patients not previously treated for BPH were studied. After
clinical examinations, symptoms of voiding, sexual and ejaculatory function were measured
using standardized IPSS, IIEF and MSHQ-EjD questionnaires. After obtaining patients’
opinion about the importance of their sex life, the therapy was chosen and possible side
effects explained. Four groups each of 39 respondents were formed. One group used alphablockers,
tamsulosin, the second 5-alpha reductase inhibitor, finasteride, the third was
administered combination therapy and the fourth control group without therapy. The
complete examination procedure was repeated after 3 and 6 months of therapy.
Results. The mean age of patients was 61.16 2.97. In the therapy groups 87% reported their
sex life was important to some degree. Satisfaction with their sex life was reported by 47% of
patients before treatment and 67% 6 months after treatment. Questionnaire indicated general
improvement of sexual function (IIEF) in all groups statistically significant compared to
baseline only in the group on alpha-blockers (2.95 7.81; p=0.028). Overall satisfaction with
sex life compared to the beginning of treatment is significantly improved only in the group
with combined therapy.
Conclusion. Before treatment BHP, should be evaluated sexual function. Customize therapy
to patient’s expectations. Present side effects of drugs, especially to those emphasizing the
importance of sex life in order to improve it.
“Data exchange” service offers individual users metadata transfer in several different formats. Citation formats are offered for transfers in texts as for the transfer into internet pages. Citation formats include permanent links that guarantee access to cited sources. For use are commonly structured metadata schemes : Dublin Core xml and ETUB-MS xml, local adaptation of international ETD-MS scheme intended for use in academic documents.